Stocks · News reference

Bruker shares are trading higher after the company announced a majority investment in MIMETAS to expand its post‑genomic solutions and advance drug discovery through microphysiological systems.

Aug 10, 2026, 2:54 PMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaSep 4, 2026, 7:51 AMBenzinga Newsdesk
Bruker, Luvata Team Up To Boost Superconductor Supply For Fusion Power Projects
Bruker Energy & Supercon Technologies (BEST), a segment of Bruker Corporation (NASDAQ:BRKR), and Luvata Materials & Solutions, a Business Unit of Luvata Group (LUVATA) today announced a strategic collaboration
BRKR
BenzingaAug 31, 2026, 5:47 PMVandana Singh
Jury Awards 10x Genomics Millions in Patent Lawsuit Against Qiagen Unit
10x Genomics won a $4.8 million patent infringement lawsuit against Qiagen subsidiary Parse Biosciences, prompting plans for an injunction.
BRKR QGEN TXG
BenzingaAug 11, 2026, 11:05 AMBenzinga Newsdesk
Bruker Announces Expanded Strategic Collaboration With And Minority Investment In Self-Driving Labs Firm Atinary Technologies; Terms Not Disclosed
BRKR